OTCs in Action Episode 58: Spots on her face


OTCs are in Action this week in parental thinking: “You don’t need a new iPhone … those shorts are too short … those heels are too high … too much make-up!” Sometimes it seems I say no to everything my teenage daughter wants … but acne products for my lovely girl’s complicated complexion – I’ll buy anything!

So, Galderma’s proposal to launch an OTC gel version of the acne-fighting ingredient, adapalene, caught my attention. The Nestlé-owned company will present its case for switching the ingredient from Rx to OTC at the 15th April meeting of the FDA’s Nonprescription Drugs Advisory Committee. It currently markets adapalene-based OTC, Differin, in Russia and Greece. According to Nicholas Hall’s DB6 global OTC sales database, the brand generated sales of $2mn in Russia in 2014, and $1mn in Greece.

In the US, Galderma’s Rx portfolio currently uses adapalene in Rx acne treatments Epiduo (0.1% and benzoyl peroxide 2.5%), Epiduo Forte (0.3% / 2.5%) and Differin – available in 0.1% and 0.3% strengths.

If anyone needs a touching reminder of those terrible teen troubles, join the 3mn viewers of Charlie McDonnell’s acne song (which sported a pop-up ad for Neutrogena skin care brand from J&J during my last visit to the site).